Back to Search
Start Over
187O Capivasertib and fulvestrant for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Subgroup analyses from the phase III CAPItello-291 trial
- Source :
- ESMO Open. 8:101376
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- Cancer Research
Oncology
Subjects
Details
- ISSN :
- 20597029
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- ESMO Open
- Accession number :
- edsair.doi...........69b5ec36d8211c821490afe63f2e0d82